Cargando…

Retrospective Analysis of Treatment Patterns in Pseudophakic Diabetic Macular Oedema Eyes Treated with Anti-VEGF

METHODS: We performed a retrospective review of outcomes in 81 pseudophakic eyes with DMO that received at least 6 anti-VEGF injections. We reviewed baseline and posttreatment optical coherence tomography images, visual acuity, prescribing patterns, time taken to deliver anti-VEGF injections, and st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Di, Jawaid, Imran, Amoaku, Winfried M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337101/ https://www.ncbi.nlm.nih.gov/pubmed/34367690 http://dx.doi.org/10.1155/2021/9967831

Ejemplares similares

Topical non‐steroidal anti‐inflammatory drugs are not the mainstay of prophylaxis and treatment for pseudophakic cystoid macular oedema
por: Levitz, Lewis M., et al.
Publicado: (2019)

Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial
por: Jukić, Anđela, et al.
Publicado: (2022)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Spontaneous onset pseudophakic malignant glaucoma secondary to zonular weakness and cilio-lenticular block
por: Wilde, Craig, et al.
Publicado: (2018)

Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes
por: Ciulla, Thomas A, et al.
Publicado: (2021)

Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
por: Amoaku, Winfried M., et al.
Publicado: (2020)

Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020)

Commentary: An option for treating resistant pseudophakic cystoid macular edema
por: Palanivelu, Mahesh Shanmugam
Publicado: (2021)

Combined Treatment of Persistent Diabetic Macular Edema with Aflibercept and Triamcinolone Acetonide in Pseudophakic Eyes
por: Petrovic, Nenad, et al.
Publicado: (2023)

Predictors of vision‐related quality of life in patients with macular oedema receiving intra‐vitreal anti‐VEGF treatment
por: Rausch‐Koster, Petra T., et al.
Publicado: (2022)

Pseudophakic cystoid macular edema: update 2016
por: Grzybowski, Andrzej, et al.
Publicado: (2016)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
por: ROA Vandekerckhove, Kristof
Publicado: (2015)

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
por: Ahmedalgabri, Rayan Hamza Mohammed, et al.
Publicado: (2022)

Pseudophakic macular edema involving epiretinal proliferation associated with macular hole
por: Batıoğlu, Figen, et al.
Publicado: (2020)

Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease
por: Gale, R, et al.
Publicado: (2017)

Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
por: Rodrigues, Magna Vanessa, et al.
Publicado: (2023)

Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema
por: Kaldırım, Havva, et al.
Publicado: (2020)

Use of ziv-aflibercept in diabetic macular edema in a Ghanaian population
por: Braimah, Imoro Zeba, et al.
Publicado: (2022)

Preliminary Report on Optical Coherence Tomography Angiography Biomarkers in Non-Responders and Responders to Intravitreal Anti-VEGF Injection for Diabetic Macular Oedema
por: Chouhan, Sanjana, et al.
Publicado: (2023)

Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
por: Ciulla, Thomas, et al.
Publicado: (2021)

The effects of intravitreal adalimumab injection on pseudophakic macular edema
por: Farvardin, Mohsen, et al.
Publicado: (2020)

Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema
por: Posch‐Pertl, Laura, et al.
Publicado: (2018)

Anti-interleukin-6 receptor therapy with tocilizumab for refractory pseudophakic cystoid macular edema
por: Pham, Brandon Huy, et al.
Publicado: (2020)

Effect of diabetic retinopathy and diabetes on the intraocular straylight in pseudophakic eyes
por: Hwang, Hyung Bin, et al.
Publicado: (2015)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Real-World Outcomes of Anti-VEGF Therapy in Diabetic Macular Oedema: Barriers to Treatment Success and Implications for Low/Lower-Middle-Income Countries
por: Sam-Oyerinde, Olapeju A., et al.
Publicado: (2023)

Multifocal Femto-PresbyLASIK in Pseudophakic Eyes
por: Pajic, Bojan, et al.
Publicado: (2021)

Split‐Window OCT biometry in pseudophakic eyes
por: Sikorski, Bartosz L., et al.
Publicado: (2022)

Ocular Characteristics of Pseudophakic Eyes with Malignant Glaucoma
por: Zhang, Yulin, et al.
Publicado: (2023)

Wavefront Derived Refraction and Full Eye Biometry in Pseudophakic Eyes
por: Mao, Xinjie, et al.
Publicado: (2016)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

Pseudophakic Cystoid Macular Edema Associated with Extrafoveal Vitreoretinal Traction
por: Martinez, Michael R, et al.
Publicado: (2011)

Pathophysiology of Transient Corneal Edema and Pseudophakic Cystoid Macular Edema
por: Han, Sang Beom, et al.
Publicado: (2015)

Topical interferon – A novel treatment for pseudophakic macular edema
por: Kawali, Ankush, et al.
Publicado: (2021)

The clinical relevance of ultra-widefield angiography findings in patients with central retinal vein occlusion and macular oedema receiving anti-VEGF therapy
por: Nicholson, Luke, et al.
Publicado: (2021)

Two-year outcomes of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema
por: Kim, Yu Cheol, et al.
Publicado: (2020)

Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney)
por: Liew, Gerald, et al.
Publicado: (2019)

Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes
por: William, Antony, et al.
Publicado: (2023)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dmm942q5b1lbv4ke7hhohsalrs